Volume 79, Issue 5, Pages (March 2011)

Slides:

Advertisements

Similar presentations

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Advertisements

Volume 83, Issue 2, Pages (February 2013)

Propofol-related green urine

Volume 85, Issue 2, Pages (January 2014)

Volume 72, Issue 1, Pages (July 2007)

Reassessment of the care of the patient with chronic kidney disease

The risk of hospitalization and modality failure with home dialysis

Volume 80, Issue 10, Pages (November 2011)

Volume 81, Issue 4, Pages (February 2012)

Volume 71, Issue 8, Pages (April 2007)

Jeffrey C. Fink, Glenn M. Chertow Kidney International

Volume 82, Issue 8, Pages (October 2012)

Volume 74, Issue 10, Pages (November 2008)

Volume 76, Issue 3, Pages (August 2009)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 81, Issue 3, Pages (February 2012)

Volume 73, Issue 7, Pages (April 2008)

Volume 76, Issue 3, Pages (August 2009)

Nephrology Crosswords: Hemodialysis

Volume 86, Issue 2, Pages (August 2014)

Volume 87, Issue 2, Pages (February 2015)

Volume 79, Issue 4, Pages (February 2011)

Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.

Nephrology Crossword: History of nephrology

Kenar D. Jhaveri, Steven Fishbane Kidney International

Volume 61, Issue 4, Pages (April 2002)

Therapy of relapsing minimal-change disease in adults: a new approach?

Volume 82, Issue 1, Pages 3-4 (July 2012)

Structure, not just function

Volume 85, Issue 3, Pages (March 2014)

A physician's perseverance uncovers problems in a key nephrology study

Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner

The third World Kidney Day: Looking back and thinking forward

Volume 74, Issue 6, Pages (September 2008)

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 74, Issue 8, Pages (October 2008)

Volume 87, Issue 3, Pages (March 2015)

Nephrology Crossword: Peritoneal Dialysis

Volume 85, Issue 1, Pages 3-4 (January 2014)

Extracorporeal removal of toxins

Nephrology Crossword: Glomerulonephritis

Volume 71, Issue 4, Pages (February 2007)

Volume 80, Issue 3, Pages (August 2011)

Volume 76, Issue 1, Pages 6-7 (July 2009)

A man with a hole in his penis

Volume 87, Issue 5, Pages (May 2015)

Volume 73, Issue 9, Pages (May 2008)

Volume 77, Issue 6, Pages (March 2010)

Volume 82, Issue 9, Pages (November 2012)

The treatment of acute interstitial nephritis: More data at last

Volume 67, Issue 1, Pages (January 2005)

Organ transplantation goes to the movies

Volume 75, Pages S47-S49 (February 2009)

Volume 55, Pages S3-S16 (June 1999)

Volume 83, Issue 4, Pages (April 2013)

This Month in AJKD American Journal of Kidney Diseases

Volume 71, Issue 9, Pages (May 2007)

Volume 74, Issue 9, Pages (November 2008)

Volume 82, Issue 9, Pages (November 2012)

The international realities of live donor kidney transplantation

Volume 75, Issue 8, Pages (April 2009)

Volume 77, Issue 12, Pages (June 2010)

Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation W. Charles O'Neill, Amy.

Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors Lynn Stothers, William A. Gourlay, Li.

Volume 86, Issue 3, Pages (September 2014)

Volume 79, Issue 10, Pages (May 2011)

Ronen Levi, Justin Silver Kidney International

Presentation transcript:

Volume 79, Issue 5, Pages 486-487 (March 2011) Journal Club Kidney International Volume 79, Issue 5, Pages 486-487 (March 2011) DOI: 10.1038/ki.2010.551 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure Immunohistochemistry of chondrogenic (first and third columns) and osteogenic (second and fourth columns) lesions from individuals with FOP with activating ALK2 mutations (bottom). Normal cartilage and bone are shown in the top. Kidney International 2011 79, 486-487DOI: (10.1038/ki.2010.551) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure Change in UACR from baseline to last measurement during treatment. Error bars represent 95% confidence intervals. P values are for the comparison of paricalcitol versus placebo. Kidney International 2011 79, 486-487DOI: (10.1038/ki.2010.551) Copyright © 2011 International Society of Nephrology Terms and Conditions